Showing 1 - 10 of 7,761
This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …. The WTO's TRIPS Agreement (TRIPS) makes it obligatory for WTO members − except least-developed country members (LDCs) - to … to be compliant with this provision of TRIPS by 2005. This study investigates two questions in this context: (1) How does …
Persistent link: https://www.econbiz.de/10011992779
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...
Persistent link: https://www.econbiz.de/10011509446
Persistent link: https://www.econbiz.de/10011925529
Persistent link: https://www.econbiz.de/10010512063
Persistent link: https://www.econbiz.de/10011563305
Persistent link: https://www.econbiz.de/10011748246
agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its … rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of …
Persistent link: https://www.econbiz.de/10009793209
Persistent link: https://www.econbiz.de/10012433548
Persistent link: https://www.econbiz.de/10012433661